On Tuesday, the Journal of the American Medical Association released results from a study on adverse drug events. The study examined nearly 42,600 cases from the National Electronic Injury Surveillance System — Cooperative Adverse Drug Event Surveillance project and found, in part, that the rate of ER visits of adults aged 65 years and older was three times that of those 65 and younger (9.7 visits per 1,000 individuals compared with 3.1, respectively.) Dig into more of the highlights in this Pharmalot story from Ed Silverman. According to the CDC, 11.9 percent of ER visits result in hospital admissions. It’s certainly not a brand new story, but it does highlight the opportunity for pharmacists to better engage with physicians and patients as a valuable part of the care team.
Gilead is in the hot seat again. Tuesday, the University of Minnesota filed in federal court defending the patent rights allegedly secured and assigned to the school by Dr. Carston Wagner, an endowed chair in medicinal chemistry at the School of Pharmacy. (The U of M, by the way, was ranked the second best pharmacy school in the nation. Go Gophers!) The drugs covered by patent, the U says—“antiviral compounds and methods for using those compounds to treat viral infections, such as that caused by hepatitis C virus”—include those that contain products that contain the drug sofosbuvir.
Here are few other stories we came across this week that you might find interesting: